Ligand Pharmaceuticals's goodwill is $100M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Ligand Pharmaceuticals (LGND) currently reports a goodwill of $100M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Ligand Pharmaceuticals's goodwill history and peer comparisons.
Ligand Pharmaceuticals's goodwill changed from $0 to $100M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Ligand Pharmaceuticals reported $100M in goodwill as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current goodwill of $100M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ligand Pharmaceuticals, and consider following LGND for alerts when major investors trade the stock.
Ligand Pharmaceuticals is classified in the Healthcare sector. On goodwill, it currently shows $100M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LGND with unrelated industries.